http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Molecular epidemiology of chronic diseases
Introduction: why molecular epidemiology? -- Study design -- Molecular epidemiological studies that can be nested within cohorts -- Family studies, haplotypes and gene association studies -- Individual susceptibility and gene-environment interaction -- Biomarker validation -- Exposure assessment -- Carcinogen metabolites as biomarkers -- Biomarkers of exposure: adducts -- Biomarkers of mutation and DNA repair capacity -- High-throughout techniques - genotyping and genomics -- Proteomics and molecular epidemiology -- Exploring the contribution of metabolic profiling to epidemiological studies -- Univariate and multivariate data analysis -- Meta-analysis and pooled analysis - genetic and environmental data -- Analysis of complex datasets -- Some implications of random exposure measurement errors in occupational and environmental epidemiology -- Bioninformatics -- Biomarkers, disease mechanisms and their role in regulatory decisions -- Biomarkers as endpoints in intervention studies -- Biological resource centres in molecular epidemiology: collecting, storing and analysing biospecimens -- Molecular epidemiology and ethics: biomarkers for disease susceptibility -- Biomarkers for dietary carcinogens: the example of heterocyclic amines in epidemiological studies -- Practical examples: hormones -- Aflatoxin, hepatitis B virus and liver cancer: a paradigm for molecular epidemiology -- Complex exposures - air pollution.
editors, Chris Wild, Paolo Vineis, Seymour Garte.
Electronic reproduction. Hoboken, N.J. : Wiley InterScience, 2008. Mode of access: World Wide Web. System requirements: Web browser. Title from title screen (viewed on Oct. 28, 2008). Access may be restricted to users at subscribing institutions.
Includes bibliographical references and index.